Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
Many fears arise in childhood. And the science is very clear. Observational fear learning is especially common in children who model their fear without parental support.
Read Full NewsFaricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration.
Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss.
The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be a false positive for cyclospora, saying the reversal does not...
Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...
Sri Lanka's public health services and hospitals are battling the worst outbreak of mosquito-borne dengue in nearly a decade, and turning to the island nation's armed...
Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.
A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.
1.
BTK Inhibitor Active in Half of Patients With Richter Transformation
2.
Testosterone recovery linked to overall survival in high-risk prostate cancer
3.
RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung
4.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
5.
Is Laughter Good for Blood Glucose Control?
1.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
2.
Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring
3.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
4.
The Power of Romiplostim in Treating Low Platelet Counts
5.
Reconstructive Tissue Engineering After Tumor Resection
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge